CJC-1295 (No DAC) + Ipamorelin Research Blend

Yes. Every batch of CJC-1295 (No DAC) + Ipamorelin Blend is tested by an independent third-party laboratory using HPLC and MS-UPLC, confirming purity and mass identity before the batch is released. Pure Peptides does not test its own material.

It means CJC-1295 (No DAC) + Ipamorelin Blend is supplied for in-vitro laboratory research and for no other purpose, and must not be administered to humans or animals. Purchasing it for in-vitro research is lawful in the United States, and it is not a controlled substance, but purchasers are responsible for ensuring their own use complies with applicable federal, state, and local regulations.

CJC-1295 (No DAC) + Ipamorelin Blend ships from US stock with cold-chain packaging and full tracking; orders placed before noon EST on business days are typically dispatched the same business day. On arrival, store the lyophilized powder at -20°C or below, dry and protected from light.

Store the lyophilized vial at -20°C or below in a dry, dark environment. Once reconstituted for in-vitro use, prepare only the volume your assay requires, and avoid repeated freezing and thawing.

For in-vitro research, the blend is reconstituted with a laboratory-appropriate diluent such as sterile water or an assay buffer, preparing only the volume your assay requires. Each component's Reference page sets out its own handling. Pure Peptides cannot advise on administration or research methods; every compound is supplied for in-vitro laboratory use only. Try the Reconstitution Calculator →

No published study has given the two together and reported the result. They appear together in review articles, and in laboratory methods for detecting peptides, but not in a study of the combination. PubMed was last checked for such a study on 24 October 2026.

HPLC separates the two peptides, so the chromatogram shows one main peak for CJC-1295 (No DAC) and one for ipamorelin. Mass spectrometry then confirms the identity of each peptide separately, by its mass. Purity is reported for each component on its own, not as one figure for the whole vial.

In published research, the name CJC-1295 belongs to a related compound that carries an extra chemical handle allowing it to stick to a blood protein. That handle is what this version leaves off. The CJC-1295 in this vial is the 29-amino-acid chain without it, also sold under the name Modified GRF(1-29).